Todo DSpace

Listar por tema "Survival Rate"

Mostrando ítems 1-20 de 26

    • Atrial fibrillation and cognitive function in patients with heart failure: a systematic review and meta-analysis 

      Myserlis P.G., Malli A., Kalaitzoglou D.K., Kalaitzidis G., Miligkos M., Kokkinidis D.G., Kalogeropoulos A.P. (2017)
      Cognitive impairment and dementia are established complications of heart failure (HF) in adult patients and impair medication adherence and self-care. Atrial fibrillation (AF) is suggested to play an independent role in ...

    • Competing mortality in patients with neuroendocrine tumors 

      Low S.K., Giannis D., Bahaie N.S., Trong B.L.H., Moris D., Huy N.T. (2019)
      Objectives: Patients with neuroendocrine tumors (NETs) are at increased risk of mortality from competing causes in light of the improvement in overall survival over recent decades. The purpose of this study was to explore ...

    • Computational genomic analysis of PARK7 interactome reveals high BBS1 gene expression as a prognostic factor favoring survival in malignant pleural mesothelioma 

      Vavougios G.D., Solenov E.I., Hatzoglou C., Baturina G.S., Katkova L.E., Molyvdas P.A., Gourgoulianis K.I., Zarogiannis S.G. (2015)
      The aim of our study was to assess the differential gene expression of Parkinson protein 7 (PARK7) interactome in malignant pleural mesothelioma (MPM) using data mining techniques to identify novel candidate genes that may ...

    • Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with Non-Vitamin-K oral anticoagulants (RAF-NOACs) Study 

      Paciaroni M., Agnelli G., Falocci N., Tsivgoulis G., Vadikolias K., Liantinioti C., Chondrogianni M., Bovi P., Carletti M., Cappellari M., Zedde M., Ntaios G., Karagkiozi E., Athanasakis G., Makaritsis K., Silvestrelli G., Lanari A., Ciccone A., Putaala J., Tomppo L., Tatlisumak T., Abdul-Rahim A.H., Lees K.R., Alberti A., Venti M., Acciarresi M., D'Amore C., Becattini C., Mosconi M.G., Cimini L.A., Soloperto R., Masotti L., Vannucchi V., Lorenzini G., Tassi R., Guideri F., Acampa M., Martini G., Sohn S.-I., Marcheselli S., Mumoli N., De Lodovici M.L., Bono G., Furie K.L., Tadi P., Yaghi S., Toni D., Letteri F., Tassinari T., Kargiotis O., Lotti E.M., Flomin Y., Mancuso M., Maccarrone M., Giannini N., Bandini F., Pezzini A., Poli L., Padovani A., Scoditti U., Denti L., Consoli D., Galati F., Sacco S., Carolei A., Tiseo C., Gourbali V., Orlandi G., Giuntini M., Chiti A., Giorli E., Gialdini G., Corea F., Ageno W., Bellesini M., Colombo G., Monaco S., Baronello M.M., Karapanayiotides T., Caso V. (2017)
      Background--The optimal timing to administer non-vitamin K oral anticoagulants (NOACs) in patients with acute ischemic stroke and atrial fibrillation is unclear. This prospective observational multicenter study evaluated ...

    • The effect of 5-azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes 

      Diamantopoulos P.T., Symeonidis A., Pappa V., Kotsianidis I., Galanopoulos A., Pontikoglou C., Anagnostopoulos A., Vassilopoulos G., Zikos P., Hatzimichael E., Papaioannou M., Megalakaki A., Repousis P., Kotsopoulou M., Dimou M., Solomou E., Dryllis G., Tsokanas D., Papoutselis M.-K., Papageorgiou S., Kyrtshonis M.-C., Kourakli A., Papadaki H., Panayiotidis P., Viniou N.-A. (2021)
      The regimen of 5-azacytidine for patients with myelodysplastic syndrome (MDS) has remained unchanged since its first approval. Although several modifications have since been made and delays and dose reductions are common ...

    • Efficacy of local administration of tranexamic acid for blood salvage in patients undergoing intertrochanteric fracture surgery 

      Drakos A., Raoulis V., Karatzios K., Doxariotis N., Kontogeorgakos V., Malizos K., Varitimidis S.E. (2016)
      Objectives: The primary aim of this study was to assess whether local administration of tranexamic acid (TXA) reduced the need for a blood transfusion in elderly patients treated with an intramedullary (IM) nail for an ...

    • Epithelial-mesenchymal transition in non small-cell lung cancer 

      Tsoukalas N., Aravantinou-Fatorou E., Tolia M., Giaginis C., Galanopoulos M., Kiakou M., Kostakis I.D., Dana E., Vamvakaris I., Korogiannos A., Tsiambas E., Salemis N., Kyrgias G., Karameris A., Theocharis S. (2017)
      Background/Aim: Lung cancer is the first cause of cancer related deaths in both males and females. Epithelial-mesenchymal transition (EMT) is a reversible process by which epithelial cells transform to mesenchymal stem ...

    • Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer patients 

      Liontos M., Trigka E.-A., Korkolopoulou P., Tzannis K., Lainakis G., Koutsoukos K., Kostouros E., Lykka M., Papandreou C.N., Karavasilis V., Christodoulou C., Papatsoris A., Skolarikos A., Varkarakis I., Adamakis I., Alamanis C., Stravodimos K., Mitropoulos D., Deliveliotis C., Constantinidis C.A., Saetta A., Patsouris E., Dimopoulos M.Α., Bamias A. (2017)
      Purpose: To identify prognostic molecular profiles in patients with mRCC treated with sunitinib, we performed immunohistochemical analysis for VEGF and PI3K/Akt/mTOR pathway components. Methods: The immunohistochemical ...

    • Expression of Fibroblast Activation Protein Is Enriched in Neuroendocrine Prostate Cancer and Predicts Worse Survival 

      Vlachostergios P.J., Karathanasis A., Tzortzis V. (2022)
      Background: Advanced prostate cancer (PC) may accumulate genomic alterations that hallmark lineage plasticity and transdifferentiation to a neuroendocrine (NE) phenotype. Fibroblast activation protein (FAP) is a key player ...

    • Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: A systematic analysis for the Global Burden of Disease Study 2016 

      Wang H., Abajobir A.A., Abate K.H., Abbafati C., Abbas K.M., Abd-Allah F., Abera S.F., Abraha H.N., Abu-Raddad L.J., Abu-Rmeileh N.M.E., Adedeji I.A., Adedoyin R.A., Adetifa I.M.O., Adetokunboh O., Afshin A., Aggarwal R., Agrawal A., Agrawal S., Ahmad Kiadaliri A., Ahmed M.B., Aichour A.N., Aichour I., Aichour M.T.E., Aiyar S., Akanda A.S., Akinyemiju T.F., Akseer N., Al-Eyadhy A., Al Lami F.H., Alabed S., Alahdab F., Al-Aly Z., Alam K., Alam N., Alasfoor D., Aldridge R.W., Alene K.A., Alhabib S., Ali R., Alizadeh-Navaei R., Aljunid S.M., Alkaabi J.M., Alkerwi A., Alla F., Allam S.D., Allebeck P., Al-Raddadi R., Alsharif U., Altirkawi K.A., Martin E.A., Alvis-Guzman N., Amare A.T., Ameh E.A., Amini E., Ammar W., Amoako Y.A., Anber N., Andrei C.L., Androudi S., Ansari H., Ansha M.G., Antonio C.A.T., Anwari P., Ärnlöv J., Arora M., Artaman A., Aryal K.K., Asayesh H., Asgedom S.W., Asghar R.J., Assadi R., Atey T.M., Atre S.R., Avila-Burgos L., Avokpaho E.F.G.A., Awasthi A., Ayala Quintanilla B.P., Babalola T.K., Bacha U., Badawi A., Balakrishnan K., Balalla S., Barac A., Barber R.M., Barboza M.A., Barker-Collo S.L., Bärnighausen T., Barquera S., Barregard L., Barrero L.H., Baune B.T., Bazargan-Hejazi S., Bedi N., Beghi E., Béjot Y., Bekele B.B., Bell M.L., Bello A.K., Bennett D.A., Bennett J.R., Bensenor I.M., Benson J., Berhane A., Berhe D.F., Bernabé E., Beuran M., Beyene A.S., Bhala N., Bhansali A., Bhaumik S., Bhutta Z.A., Bikbov B., Birungi C., Biryukov S., Bisanzio D., Bizuayehu H.M., Bjerregaard P., Blosser C.D., Boneya D.J., Boufous S., Bourne R.R.A., Brazinova A., Breitborde N.J.K., Brenner H., Brugha T.S., Bukhman G., Bulto L.N.B., Bumgarner B.R., Burch M., Butt Z.A., Cahill L.E., Cahuana-Hurtado L., Campos-Nonato I.R., Car J., Car M., Cárdenas R., Carpenter D.O., Carrero J.J., Carter A., Castañeda-Orjuela C.A., Castillo Rivas J., Castro F.F., Castro R.E., Catalá-López F., Chen H., Chiang P.P.-C., Chibalabala M., Chisumpa V.H., Chitheer A.A., Choi J.-Y.J., Christensen H., Christopher D.J., Ciobanu L.G., Cirillo M., Cohen A.J., Colquhoun S.M., Coresh J., Criqui M.H., Cromwell E.A., Crump J.A., Dandona L., Dandona R., Dargan P.I., Das Neves J., Davey G., Davitoiu D.V., Davletov K., De Courten B., De Leo D., Degenhardt L., Deiparine S., Dellavalle R.P., Deribe K., Deribew A., Des Jarlais D.C., Dey S., Dharmaratne S.D., Dherani M.K., Diaz-Torné C., Ding E.L., Dixit P., Djalalinia S., Do H.P., Doku D.T., Donnelly C.A., Dos Santos K.P.B., Douwes-Schultz D., Driscoll T.R., Duan L., Dubey M., Duncan B.B., Dwivedi L.K., Ebrahimi H., El Bcheraoui C., Ellingsen C.L., Enayati A., Endries A.Y., Ermakov S.P., Eshetie S., Eshrati B., Eskandarieh S., Esteghamati A., Estep K., Fanuel F.B.B., Faro A., Farvid M.S., Farzadfar F., Feigin V.L., Fereshtehnejad S.-M., Fernandes J.G., Fernandes J.C., Feyissa T.R., Filip I., Fischer F., Foigt N., Foreman K.J., Frank T., Franklin R.C., Fraser M., Friedman J., Frostad J.J., Fullman N., Fürst T., Furtado J.M., Futran N.D., Gakidou E., Gambashidze K., Gamkrelidze A., Gankpé F.G., Garcia-Basteiro A.L., Gebregergs G.B., Gebrehiwot T.T., Gebrekidan K.G., Gebremichael M.W., Gelaye A.A., Geleijnse J.M., Gemechu B.L., Gemechu K.S., Genova-Maleras R., Gesesew H.A., Gething P.W., Gibney K.B., Gill P.S., Gillum R.F., Giref A.Z., Girma B.W., Giussani G., Goenka S., Gomez B., Gona P.N., Gopalani S.V., Goulart A.C., Graetz N., Gugnani H.C., Gupta P.C., Gupta R., Gupta R., Gupta T., Gupta V., Haagsma J.A., Hafezi-Nejad N., Haghparast Bidgoli H., Hakuzimana A., Halasa Y.A., Hamadeh R.R., Hambisa M.T., Hamidi S., Hammami M., Hancock J., Handal A.J., Hankey G.J., Hao Y., Harb H.L., Hareri H.A., Harikrishnan S., Haro J.M., Hassanvand M.S., Havmoeller R., Hay R.J., Hay S.I., He F., Heredia-Pi I.B., Herteliu C., Hilawe E.H., Hoek H.W., Horita N., Hosgood H.D., Hostiuc S., Hotez P.J., Hoy D.G., Hsairi M., Htet A.S., Hu G., Huang H., Huang J.J., Iburg K.M., Igumbor E.U., Ileanu B.V., Inoue M., Irenso A.A., Irvine C.M.S., Islam N., Jacobsen K.H., Jaenisch T., Jahanmehr N., Jakovljevic M.B., Javanbakht M., Jayatilleke A.U., Jeemon P., Jensen P.N., Jha V., Jin Y., John D., John O., Johnson S.C., Jonas J.B., Jürisson M., Kabir Z., Kadel R., Kahsay A., Kalkonde Y., Kamal R., Kan H., Karch A., Karema C.K., Karimi S.M., Karthikeyan G., Kasaeian A., Kassaw N.A., Kassebaum N.J., Kastor A., Katikireddi S.V., Kaul A., Kawakami N., Kazanjan K., Keiyoro P.N., Kelbore S.G., Kemp A.H., Kengne A.P., Keren A., Kereselidze M., Kesavachandran C.N., Ketema E.B., Khader Y.S., Khalil I.A., Khan E.A., Khan G., Khang Y.-H., Khera S., Khoja A.T.A., Khosravi M.H., Kibret G.D., Kieling C., Kim C.-I., Kim D., Kim P., Kim S., Kim Y.J., Kimokoti R.W., Kinfu Y., Kishawi S., Kissimova-Skarbek K.A., Kissoon N., Kivimaki M., Knudsen A.K., Kokubo Y., Kopec J.A., Kosen S., Koul P.A., Koyanagi A., Kravchenko M., Krohn K.J., Kuate Defo B., Kucuk Bicer B., Kuipers E.J., Kulikoff X.R., Kulkarni V.S., Kumar G.A., Kumar P., Kumsa F.A., Kutz M., Lachat C., Lagat A.K., Lager A.C.J., Lal D.K., Lalloo R., Lambert N., Lan Q., Lansingh V.C., Larson H.J., Larsson A., Laryea D.O., Lavados P.M., Laxmaiah A., Lee P.H., Leigh J., Leung J., Leung R., Levi M., Li Y., Liao Y., Liben M.L., Lim S.S., Linn S., Lipshultz S.E., Liu S., Lodha R., Logroscino G., Lorch S.A., Lorkowski S., Lotufo P.A., Lozano R., Lunevicius R., Lyons R.A., Ma S., Macarayan E.R.K., Machado I.E., Mackay M.T., Magdy Abd El Razek M., Magis-Rodriguez C., Mahdavi M., Majdan M., Majdzadeh R., Majeed A., Malekzadeh R., Malhotra R., Malta D.C., Mantovani L.G., Manyazewal T., Mapoma C.C., Marczak L.B., Marks G.B., Martinez-Raga J., Martins-Melo F.R., Massano J., Maulik P.K., Mayosi B.M., Mazidi M., McAlinden C., McGarvey S.T., McGrath J.J., McKee M., Mehata S., Mehndiratta M.M., Mehta K.M., Meier T., Mekonnen T.C., Meles K.G., Memiah P., Memish Z.A., Mendoza W., Mengesha M.M., Mengistie M.A., Mengistu D.T., Menon G.R., Menota B.G., Mensah G.A., Meretoja A., Meretoja T.J., Mezgebe H.B., Micha R., Mikesell J., Miller T.R., Mills E.J., Minnig S., Mirarefin M., Mirrakhimov E.M., Misganaw A., Mishra S.R., Mohammad K.A., Mohammadi A., Mohammed K.E., Mohammed S., Mohan M.B.V., Mohanty S.K., Mokdad A.H., Molla Assaye A., Mollenkopf S.K., Molokhia M., Monasta L., Montañez Hernandez J.C., Montico M., Mooney M.D., Moore A.R., Moradi-Lakeh M., Moraga P., Morawska L., Moreno Velasquez I., Mori R., Morrison S.D., Mruts K.B., Mueller U.O., Mullany E., Muller K., Murthy G.V.S., Murthy S., Musa K.I., Nachega J.B., Nagata C., Nagel G., Naghavi M., Naidoo K.S., Nanda L., Nangia V., Nascimento B.R., Natarajan G., Negoi I., Nguyen C.T., Nguyen G., Nguyen Q.L., Nguyen T.H., Ningrum D.N.A., Nisar M.I., Nomura M., Nong V.M., Norheim O.F., Norrving B., Noubiap J.J.N., Nyakarahuka L., Obermeyer C.M., O'Donnell M.J., Ogbo F.A., Oh I.-H., Okoro A., Oladimeji O., Olagunju A.T., Olusanya B.O., Olusanya J.O., Oren E., Ortiz A., Osgood-Zimmerman A., Ota E., Owolabi M.O., Oyekale A.S., Mahesh P.A., Pacella R.E., Pakhale S., Pana A., Panda B.K., Panda-Jonas S., Park E.-K., Parsaeian M., Patel T., Patten S.B., Patton G.C., Paudel D., Pereira D.M., Perez-Padilla R., Perez-Ruiz F., Perico N., Pervaiz A., Pesudovs K., Peterson C.B., Petri W.A., Petzold M., Phillips M.R., Piel F.B., Pigott D.M., Pishgar F., Plass D., Polinder S., Popova S., Postma M.J., Poulton R.G., Pourmalek F., Prasad N., Purwar M., Qorbani M., Rabiee R.H.S., Radfar A., Rafay A., Rahimi-Movaghar A., Rahimi-Movaghar V., Rahman M., Rahman M.H.U., Rahman S.U., Rai R.K., Rajsic S., Ram U., Rana S.M., Ranabhat C.L., Rao P.V., Rawaf S., Ray S.E., Rego M.A.S., Rehm J., Reiner R.C., Remuzzi G., Renzaho A.M.N.N., Resnikoff S., Rezaei S., Rezai M.S., Ribeiro A.L., Rokni M.B., Ronfani L., Roshandel G., Roth G.A., Rothenbacher D., Roy A., Rubagotti E., Ruhago G.M., Saadat S., Sabde Y.D., Sachdev P.S., Sadat N., Safdarian M., Safi S., Safiri S., Sagar R., Sahathevan R., Sahebkar A., Sahraian M.A., Salama J., Salamati P., Salomon J.A., Salvi S.S., Samy A.M., Sanabria J.R., Sanchez-Niño M.D., Santos I.S., Santric Milicevic M.M., Sarmiento-Suarez R., Sartorius B., Satpathy M., Sawhney M., Saxena S., Saylan M.I., Schmidt M.I., Schneider I.J.C., Schutte A.E., Schwebel D.C., Schwendicke F., Seedat S., Seid A.M., Sepanlou S.G., Servan-Mori E.E., Shackelford K.A., Shaheen A., Shahraz S., Shaikh M.A., Shamsipour M., Shamsizadeh M., Islam S.M.S., Sharma J., Sharma R., She J., Shen J., Shetty B.P., Shi P., Shibuya K., Shigematsu M., Shiri R., Shiue I., Shrime M.G., Sigfusdottir I.D., Silberberg D.H., Silpakit N., Silva D.A.S., Silva J.P., Silveira D.G.A., Sindi S., Singh A., Singh J.A., Singh P.K., Singh V., Sinha D.N., Skiadaresi E., Sligar A., Smith D.L., Sobaih B.H.A., Sobngwi E., Soneji S., Soriano J.B., Sreeramareddy C.T., Srinivasan V., Stathopoulou V., Steel N., Stein D.J., Steiner C., Stöckl H., Stokes M.A., Strong M., Sufiyan M.B., Suliankatchi R.A., Sunguya B.F., Sur P.J., Swaminathan S., Sykes B.L., Szoeke C.E.I., Tabarés-Seisdedos R., Tadakamadla S.K., Tadese F., Tandon N., Tanne D., Tarajia M., Tavakkoli M., Taveira N., Tehrani-Banihashemi A., Tekelab T., Tekle D.Y., Temam Shifa G., Temsah M.-H., Terkawi A.S., Tesema C.L., Tesssema B., Theis A., Thomas N., Thompson A.H., Thomson A.J., Thrift A.G., Tiruye T.Y., Tobe-Gai R., Tonelli M., Topor-Madry R., Topouzis F., Tortajada M., Tran B.X., Truelsen T., Trujillo U., Tsilimparis N., Tuem K.B., Tuzcu E.M., Tyrovolas S., Ukwaja K.N., Undurraga E.A., Uthman O.A., Uzochukwu B.S.C., Van Boven J.F.M., Varakin Y.Y., Varughese S., Vasankari T., Vasconcelos A.M.N., Venketasubramanian N., Vidavalur R., Violante F.S., Vishnu A., Vladimirov S.K., Vlassov V.V., Vollset S.E., Vos T., Waid J.L., Wakayo T., Wang Y.-P., Weichenthal S., Weiderpass E., Weintraub R.G., Werdecker A., Wesana J., Wijeratne T., Wilkinson J.D., Wiysonge C.S., Woldeyes B.G., Wolfe C.D.A., Workicho A., Workie S.B., Xavier D., Xu G., Yaghoubi M., Yakob B., Yalew A.Z., Yan L.L., Yano Y., Yaseri M., Ye P., Yimam H.H., Yip P., Yirsaw B.D., Yonemoto N., Yoon S.-J., Yotebieng M., Younis M.Z., Zaidi Z., El Sayed Zaki M., Zeeb H., Zenebe Z.M., Zerfu T.A., Zhang A.L., Zhang X., Zodpey S., Zuhlke L.J., Lopez A.D., Murray C.J.L., GBD 2016 Mortality Collaborators (2017)
      Background: Detailed assessments of mortality patterns, particularly age-specific mortality, represent a crucial input that enables health systems to target interventions to specific populations. Understanding how all-cause ...

    • Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin within the Normal Range and Normalization of Alkaline Phosphatase 

      Murillo Perez C.F., Harms M.H., Lindor K.D., Van Buuren H.R., Hirschfield G.M., Corpechot C., Van Der Meer A.J., Feld J.J., Gulamhusein A., Lammers W.J., Ponsioen C.Y., Carbone M., Mason A.L., Mayo M.J., Invernizzi P., Battezzati P.M., Floreani A., Lleo A., Nevens F., Kowdley K.V., Bruns T., Dalekos G.N., Gatselis N.K., Thorburn D., Trivedi P.J., Verhelst X., Parés A., Janssen H.L.A., Hansen B.E. (2020)
      INTRODUCTION:In primary biliary cholangitis (PBC), bilirubin and alkaline phosphatase (ALP) are widely established as independent predictors of prognosis. Current treatment goals do not aim for normalization of surrogate ...

    • Graphical and demographic synopsis of the captive cohort method for estimating population age structure in the wild 

      Carey, J. R.; Müller, H. G.; Wang, J. L.; Papadopoulos, N. T.; Diamantidis, A.; Koulousis, N. A. (2012)
      The purpose of this paper is to complement the literature concerned with the captive cohort method for estimating age structure including (1) graphic techniques to visualize and thus better understand the underlying life ...

    • In silico methods for the identification of diagnostic and favorable prognostic markers in acute myeloid leukemia 

      Yılmaz H., Toy H.I., Marquardt S., Karakülah G., Küçük C., Kontou P.I., Logotheti S., Pavlopoulou A. (2021)
      Acute myeloid leukemia (AML), the most common type of acute leukemia in adults, is mainly asymptomatic at early stages and progresses/recurs rapidly and frequently. These attributes necessitate the identification of ...

    • Lymph node ratio as a prognostic factor in gastric cancer patients following D1 resection. Comparison with the current TNM staging system 

      Bouliaris K., Rachiotis G., Diamantis A., Christodoulidis G., Polychronopoulou E., Tepetes K. (2017)
      Introduction Nodal ratio (NR) has been demonstrated to be an independent prognostic factor in patients with gastric cancer. We evaluated the prognostic role of NR comparing it with the current TNM (2010) classification in ...

    • Microvessel Density as a Surrogate Prognostic Marker in Patients with Multiple Myeloma: A Meta-Analysis 

      Ntellas P., Perivoliotis K., Dadouli K., Koukoulis G.K., Ioannou M. (2017)
      Bone marrow (BM) angiogenesis is considered a hallmark of multiple myeloma (MM) development and progression, and can be quantified with the use of microvessel density (MVD). The purpose of this study is to provide a review ...

    • Oxidative stress in hemodialysis: Causative mechanisms, clinical implications, and possible therapeutic interventions 

      Liakopoulos V., Roumeliotis S., Zarogiannis S., Eleftheriadis T., Mertens P.R. (2019)
      Oxidative stress (OS) is the result of prooxidant molecules overwhelming the antioxidant defense mechanisms. Hemodialysis (HD) constitutes a state of elevated inflammation and OS, due to loss of antioxidants during dialysis ...

    • Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS Trial 

      Ntaios G., Pearce L.A., Veltkamp R., Sharma M., Kasner S.E., Korompoki E., Milionis H., Mundl H., Berkowitz S.D., Connolly S.J., Hart R.G. (2020)
      Background and Purpose - Emboli in embolic stroke of undetermined source (ESUS) may originate from various potential embolic sources (PES), some of which may respond better to anticoagulation, whereas others to antiplatelets. ...

    • Predicting technique and patient survival over 12 months in peritoneal dialysis: the role of anxiety and depression 

      Griva K., Kang A.W.C., Yu Z.L., Lee V.Y.W., Zarogianis S., Chan M.C., Foo M. (2016)
      Background: Emotional distress is common in dialysis patients, but its role on clinical outcomes for patients on peritoneal dialysis (PD) is uncertain. Purpose: To evaluate the effect of depression and anxiety on 1-year ...

    • Primary extranodal non Hodgkin's lymphoma of the head and neck in adults: A clinicopathological comparison between tonsillar and non tonsillar lymphomas 

      Economopoulos, T.; Fountzilas, G.; Kostourou, A.; Daniilidis, J.; Pavlidis, N.; Andreopoulou, H.; Nicolaou, A.; Papageorgiou, E.; Mellou, S.; Dervenoulas, J.; Stathakis, N. (1998)
      Primary extranodal NHL of the head and neck (HN-NHL) accounts for 10-20% of all cases of NHL. Despite their frequency, the natural history and biological behaviour of these lymphomas is poorly understood. In this study we ...

    • Primary High-Grade Non-Muscle-Invasive Bladder Cancer: High NFκB Expression in Tumor Specimens Distinguishes Patients Who are at Risk for Disease Progression 

      Mitrakas L., Gravas S., Papandreou C., Koukoulis G., Karasavvidou F., Dimakopoulos G., Weingärtner K., Karatzas A., Zachos I., Tzortzis V. (2019)
      To investigate the potential prognostic role of NFκB expression in primary high-grade non-muscle-invasive bladder cancer. Patients with primary high-grade non-muscle-invasive bladder cancer who received induction and ...